Belpointe Asset Management LLC Crispr Therapeutics Ag Transaction History

Belpointe Asset Management LLC

  • $1.51 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$39.19 - $65.67 $48,634 - $81,496
1,241 New
1,241 $50,000
Q4 2021

Feb 15, 2022
SELL
$70.09 - $111.29 $107,658 - $170,941
-1,536 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$110.2 - $156.64 $59,067 - $83,959
536 Added 53.6%
1,536 $173,000
Q2 2021

Aug 09, 2021
SELL
$100.84 - $161.89 $163,058 - $261,776
-1,617 Reduced 61.79%
1,000 $162,000
Q1 2021

May 14, 2021
BUY
$110.72 - $210.04 $289,754 - $549,674
2,617 New
2,617 $319,000

Others Institutions Holding CRSP

# of Institutions
488
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.27B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email